Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) announced that the FDA's Arthritis Advisory Committee will review XIAFLEX during an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE